Frontlight ResearchEarly access
Trial site
Russian Scientific and Research Institute of Hematology and Transfusiology of Federal Medical Biological Agency
- 1running trial
The trials here
What the trial at this site is about, from its registry record.
Running trials
Active, not recruiting
Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.
Site data: ClinicalTrials.govUpdated 12 Nov 2026